People tend to forget that big-pharma is also big business, and that businesses are out there to make money -- even from the sick and the poor. So it's a bit of a shock when you find a big drug company kicking the tried and true habit -- instead of marketing a new drug in first world countries at exorbitant prices to make their ROI, then turning it lose to where it's need more -- they're doing the reverse -- marketing it cheaply to the third world countries, doing good, and planning to make a profit as well. But it's not just the good heart of the drug companies that is changing the dominant trend -- it's western governments, non-profit organizations, and donors -- most notably, Bill Gates, that's pitching in the money needed to pay for the drugs for the third world countries. There is hope, with a slew of new drugs in the pipeline, ready for clinical trials that will most likely occur in third world countries as well, before the massive rollout.
Comments
Post a Comment